Dr. D’Costa has been involved in developing and optimizing processes for preclinical and clinical gene therapy vector production at Brammer Bio.  She has also been integral to developing robust QC analytics for incoming starting and raw materials and for the release of the clinical vector products at Brammer Bio.  Dr. D’Costa received her Doctoral degree in Biology (specializing in Molecular Virology) from Texas Tech University at Lubbock, TX.